Evaluation of nano spray drying as a method for drying and formulation of therapeutic peptides and proteins

Frontiers in Pharmacology

Volumn 6, Issue JUL, 2015, Pages

  Haggag, Yusuf A ^a,b   Faheem, Ahmed M ^a,b  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b Tanta University   (Egypt)

Author keywords

Microparticles; Nanoparticles; Peptides; Proteins; Spray drying

Indexed keywords

BETA GALACTOSIDASE; BOVINE SERUM ALBUMIN; CREMOPHOR; CYCLODEXTRIN; HYDROXYPROPYLMETHYLCELLULOSE; INSULIN; INULIN; LACTOSE; MANNITOL; NANOPARTICLE; POLOXAMER; POLYVINYL ALCOHOL; TREHALOSE; VILDAGLIPTIN;

AQUEOUS SOLUTION; BIOLOGICAL ACTIVITY; CHEMICAL STRESS; COST EFFECTIVENESS ANALYSIS; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; FREEZE DRYING; HUMAN; NANODEVICE; NANOEMULSION; NANOENCAPSULATION; NANOFABRICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PARTICLE SIZE; PROTEIN AGGREGATION; PROTEIN STABILITY; SENSITIVITY ANALYSIS; SPRAY DRYING;

EID: 84940032863     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2015.00140     Document Type: Note

References (38)

1. Adler, M., and Lee, G. (1999). Stability and surface activity of lactate dehydrogenase in spray dried trehalose. J. Pharm. Sci. 88, 199-208. doi: 10.1021/js980321x.
2. Alcock, R., Blair, J. A., O'Mahony, D. J., Raoof, A., and Quirk, A. V. (2002). Modifying the release of leuprolide from spray dried OED microparticles. J. Control. Release 82, 429-440. doi: 10.1016/S0168-3659(02)00165-7.
3. Ameri, M., and Maa, Y. F. (2006). Spray drying of biopharmaceuticals: stability and process considerations. Dry. Technol. 24, 763-768. doi: 10.1080/03602550600685275.
4. Bittner, B., Morlock, M., Koll, H., Winter, G., and Kissel, T. (1998). Recombinant human erythropoietin (rhEPO) loaded poly (lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics. Eur. J. Pharm. Biopharm. 45, 295-305. doi: 10.1016/S0939-6411(98)00012-5.
5. Blanco-Príeto, M. J., Besseghir, K., Zerbe, O., Andris, D., Orsolini, P., Heimgartner, F., et al. (2000). In vitro and in vivo evaluation of a somatostatin analogue released from PLGA microspheres. J. Control. Release 67, 19-28. doi: 10.1016/S0168-3659(99)00289-8.
6. Broadhead, J., Edmon Rouan, S. K., Hau, I., and Rhodes, C. T. (1994). The effect of process and formulation variables on the properties of spray-dried β-galactosidase. J. Pharm. Pharmacol. 46, 458-467. doi: 10.1111/j.2042-7158.1994.tb03828.x.
7. Broadhead, J., Ronan, S., Hau, I., and Rhodes, C. (1993). The effect of process and formulation variables on the properties of spray dried β-galactosidase. J. Pharm. Pharmacol. 46, 458-467. doi: 10.1111/j.2042-7158.1994.tb03828.x.
8. Broadhead, J., Rouan, S. K. E., and Rhodes, C. T. (1992). The spray drying of pharmaceuticals. Drug Dev. Ind. Pharm. 18, 1169-1206. doi: 10.3109/03639049209046327.
9. Bürkia, K., Jeona, I., Arpagausb, C., and Betza, G. (2011). New insights into respirable protein powder preparation using a nano spray dryer inter. J. Pharmaceutics 408, 248-256 doi: 10.1016/j.ijpharm.2011.02.012.
10. Cabral-Marques, H., and Almeida, R. (2009). Optimisation of spray-drying process variables for dry powder inhalation (DPI) formulations of corticosteroid/cyclodextrin inclusion complexes. Eur. J. Pharm. Biopharm. 73, 121-129. doi: 10.1016/j.ejpb.2009.05.002.
11. Cal, K., and Sollohub, K. (2010). Spray drying technique. I. Hardware and process parameters. J. Pharm. Sci. 99, 575-586. doi: 10.1002/jps.21886.
12. Chan, H. K. (2003). "Formulation challenges: protein powders for inhalation," in Modified-Release Drug delivery Technology, eds M. J. Rathbone, J. Hadgraft, and M. S. Roberts (New York, NY: Marcel Dekker).
13. Franks, F., Hatley, R. H. M., and Mathias, S. F. (1991). Materials science and the production of shelf stable biologicals. Bio Pharm. 4, 38.
14. Gavini, E., Sanna, V., Juliano, C., and Giunchedi, P. (2003). Compressed biodegradable matrices of spray-dried PLGA microspheres for the modified release of Ketoprofen. J. Microencapsul. 20, 193-201. doi: 10.3109/02652040309178061.
15. Giunchedi, P., and Conte, U. (1995). Spray-drying as a preparation method of microparticulate drug delivery systems: an overview. STP Pharm. Sci. 5, 276-290.
16. Giunchedi, P., Conti, B., Genta, I., Conte, U., and Puglisi, G. (2001). Emulsion spray-drying for the preparation of albumin-loaded PLGA microspheres. Drug Dev. Ind. Pharm. 27, 745-750. doi: 10.1081/DDC-100107331.
17. Haj-Ahmad, R., Elkordy, A., Chaw, C., and Moore, A. (2013). Compare and contrast the effects of surfactants (Pluronic®F-127 and Cremophor®EL) and sugars (beta-cyclodextrin and inulin) on properties of spray dried and crystallised lysozyme. Eur. J. Pharm. Sci. 49, 519-534. doi: 10.1016/j.ejps.2013.05.004.
18. Harsha, S. N., Aldhubiab, B. E., Nair, A. B., Alhaider, I. A., Attimarad, M., Venugopala, K. N., et al. (2015). Nanoparticle formulation by Büchi B-90 Nano Spray Dryer for oral mucoadhesion. Drug Des. Devel. Ther. 9, 273-282. doi: 10.2147/DDDT.S66654.
19. Heng, D., Lee, S. H., Ng, W. K., and Tan, R. B. (2011). The Nano Spray Dryer B-90. Expert Opin. Drug Deliv. 8, 965-972. doi: 10.1517/17425247.2011.588206.
20. Johnson, K. A. (1997). Preparation of peptide and protein powders for inhalation. Adv. Drug. Deliv. Rev. 26, 3-15 doi: 10.1016/s0169-409x(97)00506-1.
21. Lee, G. (2002). Spray-drying of proteins. Pharm. Biotechnol. 13, 135-158. doi: 10.1007/978-1-4615-0557-0_6.
22. Lee, S., Heng, D., Ng, W. K., Chan, H., and Tan, H. (2011). Nano spray drying: a novel method for preparing protein nanoparticles for protein therapy. Int. J. Pharm. 403, 192-200. doi: 10.1016/j.ijpharm.2010.10.012.
23. Li, X., Anton, N., Arpagaus, C., Belleteix, F., and Vandamme, T. F. (2010). Nanoparticles by spray drying using innovative new technology: the Büchi Nano Spray Dryer B-90. J. Control. Release 147, 304-310. doi: 10.1016/j.jconrel.2010.07.113.
24. Maaand, Y. F., and Prestrelski, S. J. (2000). Biopharmaceutical powders: particle formation and formulation considerations. Curr. Pharm. Biotechnol. 1, 283-302. doi: 10.2174/1389201003378898.
25. Maltesen, M. J., and van de Weert, M. (2008). Drying methods for protein pharmaceuticals. Drug Discov. Today Technol. 5, e81-e88. doi: 10.1016/j.ddtec.2008.11.001.
26. Marreto, R. N., Freire, J. T., and Freitas, L. A. P. (2006). Drying of pharmaceuticals: the applicability of spouted beds. Dry Technol. 24, 327-338. doi: 10.1080/07373930600564324.
27. Masters, K. (1972). Spray Drying Handbook, 3rd Edn. London: George Godwin Limited.
28. Patton, J. S., Bukar, J., and Nagarajan, S. (1999). Inhaled insulin. Adv. Drug. Deliv. Rev. 35, 235-247. doi: 10.1016/S0169-409X(98)00074-X.
29. Patton, J. S., and Byron, P. R. (2007). Inhaling medicines: delivering drugs to the body through the lungs. Nat. Rev. Drug Discov. 6, 67-74. doi: 10.1038/nrd2153.
30. Schafrothb, N., Arpagausb, C., Jadhava, U. Y., Maknea, S., and Douroumisa, D. (2012). Nano and microparticle engineering of water insoluble drugs using a novel spray-drying process. Colloids Surf. B Biointerfaces 90, 8-15. doi: 10.1016/j.colsurfb.2011.09.038.
31. Schmid, K., Arpagaus, C., and Friess, W. (2011). Evaluation of the Nano Spray Dryer B-90 for pharmaceutical applications. Pharm. Dev. Technol. 16, 287-294. doi: 10.3109/10837450.2010.485320.
32. Sollohub, K., and Cal, K. (2010). Spray drying technique II: current applications in pharmaceutical technology. J. Pharm. Sci. 99, 587-597. doi: 10.1002/jps.21963.
33. Sun, S., Liang, N., Yamamoto, H., Kawashima, Y., Cui, F., and Yan, P. (2015). pH-sensitive poly(lactide-co-glycolide) nanoparticle composite microcapsules for oral delivery of insulin. Int. J. Nanomed. 10, 3489-3498. doi: 10.2147/IJN.S81715.
34. Tzannis, S., and Prestrelski, S. (1999). Activity-stability considerations of trypsinogen during spray drying: effects of sucrose. J. Pharm. Sci. 88, 349-359. doi: 10.1021/js980011e.
35. Vehring, R. (2008). Pharmaceutical particle engineering via spray drying. Pharm. Res. 25, 999-1022. doi: 10.1007/s11095-007-9475-1.
36. Wang, J., Byrne, J. D., Napier, M. E., and Desimone, J. M. (2011). More effective nanomedicines through particle design. Small 7, 1919-1931. doi: 10.1002/smll.201100442.
37. Webb, S. D., Golledge, S. L., and Randolph, T. W. (2002). Surface adsorption of recombinant human interferon-g in lyophilized and spray-lyophilized formulations. J. Pharm. Sci. 91, 1474-1487. doi: 10.1002/jps.10135.
38. Zauner, W., Farrow, N. A., and Haines, A. M. (2001). In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density. J. Control. Release 71, 39-51. doi: 10.1016/S0168-3659(00)00358-8.